TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 25nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 51nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 61nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 78nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 81nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 89nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 94nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 105nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibition of human integrin alpha-4-beta-1-mediated Ramos cell adhesion to immobilized VCAM1More data for this Ligand-Target Pair
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair